Why the study?
Does levosimendan infusion lead to rapid changes in BNP and NT-proBNP levels corresponding to hemodynamic improvements in patients with decompensated heart failure?
Population
11 consecutive patients with acute decompensation of chronic heart failure requiring hemodynamic monitoring…
Design
Cohort
Follow-up
24 hours
Authors
Loading...
Early BNP decline may mark rapid levosimendan response in decompensated HF; leaves open whether it should guide therapy over NT-proBNP.
Does levosimendan infusion lead to rapid changes in BNP and NT-proBNP levels corresponding to hemodynamic improvements in patients with decompensated heart failure?
BNP responds more rapidly than NT-proBNP to hemodynamic improvements during levosimendan therapy in decompensated heart failure, reflecting its shorter biological half-life.
Gegenhuber et al. (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: